rs121913013

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001943.5(DSG2):​c.166G>A​(p.Val56Met) variant causes a missense change. The variant allele was found at a frequency of 0.00244 in 1,614,130 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 8 hom. )

Consequence

DSG2
NM_001943.5 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:6B:20O:1

Conservation

PhyloP100: 6.62
Variant links:
Genes affected
DSG2 (HGNC:3049): (desmoglein 2) This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11316037).
BP6
Variant 18-31519887-G-A is Benign according to our data. Variant chr18-31519887-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 16818.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=14, Benign=1, Uncertain_significance=3}. Variant chr18-31519887-G-A is described in Lovd as [Benign]. Variant chr18-31519887-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00179 (273/152258) while in subpopulation NFE AF= 0.00316 (215/68020). AF 95% confidence interval is 0.00281. There are 1 homozygotes in gnomad4. There are 112 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 273 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DSG2NM_001943.5 linkuse as main transcriptc.166G>A p.Val56Met missense_variant 3/15 ENST00000261590.13 NP_001934.2
DSG2XM_047437315.1 linkuse as main transcriptc.-369G>A 5_prime_UTR_variant 4/16 XP_047293271.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DSG2ENST00000261590.13 linkuse as main transcriptc.166G>A p.Val56Met missense_variant 3/151 NM_001943.5 ENSP00000261590 P1

Frequencies

GnomAD3 genomes
AF:
0.00179
AC:
273
AN:
152138
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00316
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00189
AC:
471
AN:
249490
Hom.:
2
AF XY:
0.00187
AC XY:
253
AN XY:
135360
show subpopulations
Gnomad AFR exome
AF:
0.000323
Gnomad AMR exome
AF:
0.00197
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.000222
Gnomad SAS exome
AF:
0.000294
Gnomad FIN exome
AF:
0.000417
Gnomad NFE exome
AF:
0.00323
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00251
AC:
3672
AN:
1461872
Hom.:
8
Cov.:
31
AF XY:
0.00243
AC XY:
1767
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.000329
Gnomad4 AMR exome
AF:
0.00199
Gnomad4 ASJ exome
AF:
0.000153
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.000313
Gnomad4 FIN exome
AF:
0.000562
Gnomad4 NFE exome
AF:
0.00307
Gnomad4 OTH exome
AF:
0.00144
GnomAD4 genome
AF:
0.00179
AC:
273
AN:
152258
Hom.:
1
Cov.:
32
AF XY:
0.00150
AC XY:
112
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.000602
Gnomad4 AMR
AF:
0.00137
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00316
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00268
Hom.:
2
Bravo
AF:
0.00182
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000532
AC:
2
ESP6500EA
AF:
0.00353
AC:
29
ExAC
AF:
0.00187
AC:
226
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00333
EpiControl
AF:
0.00314

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:6Benign:20Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:7
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesApr 27, 2022- -
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024DSG2: BP4 -
Arrhythmogenic right ventricular dysplasia 10 Pathogenic:1Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 19, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 01, 2008- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingEquipe Genetique des Anomalies du Developpement, Université de BourgogneNov 21, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterJul 20, 2017- -
not specified Uncertain:1Benign:4
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 25, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 18, 2015p.Val56Met in exon 3 of DSG2: This variant has been reported in at least 4 indiv iduals with ARVC and was initially believed to be pathogenic (Syrris 2007, Bhuiy an 2009, Den Haan 2009, Christensen 2010, Quarta 2011). However, it has been ide ntified in 0.3% (185/66660) of European chromosomes (including 1 homozygous indi vidual) by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs121913013), strongly arguing against a disease causing role when pres ent in isolation. There is some evidence that the p.Val56Met variant may predisp ose to dilated cardiomyopathy as Posch 2008 detected it in 13/538 DCM probands v ersus 3/617 control individuals (p<0.007), but this study has not been replicate d nor firmly established. In summary, the p.Val56Met variant is unlikely to be d isease causing in isolation, but its increased frequency in patients with DCM ve rsus healthy controls raises the possibility that it acts as a modifier when pre sent together with other variants. -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 28, 2023Variant summary: DSG2 c.166G>A (p.Val56Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0019 in 253524 control chromosomes in the gnomAD database, including 2 homozygotes. The observed variant frequency is approximately 8 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSG2 causing Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy phenotype (0.00025), strongly suggesting that the variant is benign. c.166G>A has been reported in the literature in individuals affected with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and DCM (Syrris_2007, Posch_2008, Christensen_2010, Dalal_2009, Bhuyian_2009, Quarta_2011). However, the high presence of the variant in the general population and in controls suggests against a disease causing role for this variant. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 18382419, 18678517, 17105751, 19039334, 19358943, 20031616, 19955750, 20152563, 20857253, 20716751, 21606390, 20864495, 19569224, 21455723, 20031617, 29038103, 35087879). Multiple submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as likely benign (n=9) and VUS (n=4). Based on the evidence outlined above, the variant was classified as likely benign. -
Uncertain significance, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteJan 30, 2017- -
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Likely benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Uncertain significance, no assertion criteria providedresearchCSER _CC_NCGL, University of WashingtonJun 01, 2014- -
Cardiomyopathy Benign:2
Likely benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioFeb 03, 2022- -
Likely benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthApr 08, 2018- -
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingBlueprint GeneticsJul 23, 2014- -
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingBlueprint GeneticsJul 23, 2014- -
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoFeb 11, 2018- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 29, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
DSG2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 03, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Dilated cardiomyopathy 1BB Other:1
risk factor, no assertion criteria providedliterature onlyOMIMSep 01, 2008- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
26
DANN
Benign
0.96
DEOGEN2
Benign
0.17
T;T
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.83
T;D
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
1.5
L;.
MutationTaster
Benign
0.0000017
A;A
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.80
N;.
REVEL
Uncertain
0.29
Sift
Uncertain
0.012
D;.
Sift4G
Uncertain
0.052
T;D
Polyphen
1.0
D;.
Vest4
0.51
MVP
0.71
MPC
0.40
ClinPred
0.045
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.12
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121913013; hg19: chr18-29099850; COSMIC: COSV55198165; API